6505--camphor/salicylate

Closed Solicitation Posted

This opportunity was awarded. See the award notice from .

Solicitation number
36C77025Q0153
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs Veterans Health Administration (VA VHA) is seeking to procure Camphor/Menthol/Methyl Salicylate Patches through Request for Quote (RFQ) 36C77025Q0153. The solicitation requires vendors to provide pharmaceutical products with specific delivery and quality requirements, including a minimum 12-month expiration date from delivery and compliance with the Drug Supply Chain Security Act. Quotes are due by February 19, 2025, at 10:00 AM CST, and vendors must submit a comprehensive package including a signed SF1449, pricing schedule, state wholesale distributor license, and Buy American Certificate. The government will evaluate offers in accordance with FAR Part 25 policies, with a strong preference for U.S.-manufactured products. Vendors must be authorized dealers or distributors and provide documentation verifying their status.

The solicitation is set aside 100% for small businesses under NAICS code 325412, with a size standard of 1,300 employees. The contract involves delivering 12,780 boxes (60-count) of Camphor/Menthol/Methyl Salicylate Patches to the VA Consolidated Mail Outpatient Pharmacy (CMOP) in Tucson for a base period and one option period. Products must be shippable via USPS and comply with unit-of-use package bar coding requirements. Multiple lot numbers and partial deliveries require prior approval from the Contracting Officer. The base period delivery is required by March 4, 2025, with the option period requiring at least 15 days' notice before the needed delivery date. Quotes should be submitted to larry.zaritz@va.gov, with vendors limited to one quote submission.

Notice text

3 versions

Update #3 · Latest ·

AMENDMENT 002 NO ADDITIONAL CONTENT

Update #2 ·

Amendment 001 being issued to provide Clarification on delivery under Option Period I

Update #1 ·

52.225-2 BUY AMERICAN CERTIFICATE (OCT 2022)

(a)(1) The Offeror certifies that each end product, except those listed in paragraph (b) of this provision, is a domestic end product and that each domestic end product listed in paragraph (c) of this provision contains a critical component.

(2) The Offeror shall list as foreign end products those end products manufactured in the United States that do not qualify as domestic end products. For those foreign end products that do not consist wholly or predominantly of iron or steel or a combination of both, the Offeror shall also indicate whether these foreign end products exceed 55 percent domestic content, except for those that are COTS items. If the percentage of the domestic content is unknown, select no .

(3) The Offeror shall separately list the line item numbers of domestic end products that contain a critical component (see FAR 25.105).

(4) The terms commercially available off-the-shelf (COTS) item, critical component, domestic end product, end product, and foreign end product are defined in the clause of this solicitation entitled Buy American Supplies.

(b) Foreign End Products:

Line item No.

Country of origin

Exceeds 55% domestic content (yes/no)

[List as necessary]

(c) Domestic end products containing a critical component:

Line item No.

[List as necessary]

(d) The Government will evaluate offers in accordance with the policies and procedures of part 25 of the Federal Acquisition Regulation.

(C$END-OF-PROV)

Files

File Type Posted
36C77025Q0153 0002.docx DOCX document
36C77025Q0153 0001.docx DOCX document
Pharmaceutical Pricing Schedule C1625 Amended 0001.xlsx XLSX spreadsheet
Pharmaceutical Pricing Schedule C1625.xlsx XLSX spreadsheet
52.225-2 BUY AMERICAN CERTIFICATE 02.docx DOCX document
36C77025Q0153.docx DOCX document

Notice history

Notice Type Posted
6505--36C77025Q0153 - camphor/salicylate tucson cmop Award Award Notice
This notice Latest solicitation Solicitation
6505--camphor/salicylate Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
Pad,heat treatment Medical Supply Chain No set-aside
Dibucaine ointment Medical Supply Chain No set-aside
6515--Omnicell Pharmacy VA Long Beach Healthcare System Long Beach CA 90822, United States · NAICS 339113 Veterans Integrated Service Network 22 No set-aside
EMOLLIENT LOTION and 2 more items Medical Supply Chain No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors